IONS

Ionis Pharmaceuticals Stock Analysis

AI Rating

Good
  • Quality1/10
  • Growth↑ 7/10
  • Momentum↑ 9/10
Ionis Pharmaceuticals sales and earnings growth
IONS Growth
Good
  • Revenue Y/Y↑ 20.41%
  • EPS Y/Y↑ 34.02%
  • FCF Y/Y↑ 18.39%
Ionis Pharmaceuticals gross and profit margin trends
IONS Profitability
Neutral
  • Gross margin ↑ 98.80%
  • EPS margin↓ -26.50%
  • ROIC↓ -4.80%
Ionis Pharmaceuticals net debt vs free cash flow
IONS Risk
Fair
  • Debt / Equity↑ 2.4
  • Debt / FCF↓ 3.8
  • Interest coverage↓ -1.8

Ionis Pharmaceuticals stock is less volatile than the overall market, so it's low risk. We give it a Fair risk rating.

More Biotechnology stocks ↗